| Trial ID: | L3922 |
| Source ID: | NCT00612950
|
| Associated Drug: |
Glucagon-Like Peptide-1,
|
| Title: |
Beta-Cell Function After Near-Normalisation of Blood Glucose
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: glucagon-like peptide-1,|DRUG: glucose dependent insulinotropic polypeptide|DRUG: Saline
|
| Outcome Measures: |
Primary: 2.phase insulin response measured as incremental area under the curve from 10-120 minutes, 2 hours | Secondary: 2.phase insulin response measured as incremental area under the curve from 10-120 minutes, after 4 weeks of insulin treatment, 2 hours
|
| Sponsor/Collaborators: |
Sponsor: Hvidovre University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
8
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2006-10
|
| Completion Date: |
2007-05
|
| Results First Posted: |
|
| Last Update Posted: |
2008-02-12
|
| Locations: |
Dept. of Endocrinology, Hvidovre Hospital, Copenhagen, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00612950
|
